X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 26/Jun 12:35

Is It Apt to Hold Quest Diagnostics (DGX) Stock for Now?

Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues pose concerns.

Articles similaires

Sorry! Image not available at this time

Here's Why Hold Strategy is Apt for Kinder Morgan (KMI) Stock

zacks.com - 28/Jun 11:52

Kinder Morgan (KMI) generates stable fee-based revenues from its vast network of midstream infrastructure. However, a slowdown in drilling activities...

Sorry! Image not available at this time

Here's Why Investors Should Retain Golar LNG (GLNG) Stock Now

zacks.com - 26/Jun 13:14

Golar LNG's (GLNG) shareholder-friendly approach bodes well for the company. However, GLNG is grappling with a surge in vessel operating expenses.

Sorry! Image not available at this time

Here's Why Hold Strategy is Apt for EOG Resources (EOG) Stock

zacks.com - 24/Jun 14:01

EOG Resources (EOG) is dedicated to sustainability and resilience, with emission reduction pathways and water reuse programs positioning it well in...

Sorry! Image not available at this time

Quest Diagnostics (DGX) Inks Deal to Acquire Allina Health

zacks.com - 27/Jun 13:43

Quest Diagnostics (DGX) signs an agreement to acquire Allina Health's select laboratory assets. The deal is aimed at expanding Quest Diagnostics'...

Sorry! Image not available at this time

Quest Diagnostics to acquire LifeLabs from OMERS for C$1.35 billion

themarketherald.ca - 03/Jul 17:13

Quest Diagnostics (NYSE:DGX) signs an agreement to acquire LifeLabs from OMERS in a C$1.35 billion deal, including net debt.

Sorry! Image not available at this time

Colgate's (CL) Strategic Efforts Seem Prudent: Apt to Hold?

zacks.com - 26/Jun 15:01

Colgate (CL) benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.

Sorry! Image not available at this time

Reasons Why You Should Hold Roper (ROP) in Your Portfolio Now

zacks.com - 03/Jul 12:56

Roper (ROP) gains from solid momentum in its businesses, acquired assets and shareholder-friendly moves. However, rising operating costs and high...

Key GOP economic talking point destroyed by new analysis

rawstory.com - 24/Jun 13:37

National debt has for decades been a go-to issue Republicans try to use to persuade voters against supporting social programs — an issue that has...

Sorry! Image not available at this time

Here's Why You Should Hold Green Dot (GDOT) Stock for Now

zacks.com - 28/Jun 12:18

GO2bank will be the key driver of Green Dot's (GDOT) revenues going forward.

Sorry! Image not available at this time

Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now

zacks.com - 26/Jun 11:44

Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.